Use of recombinant interferon omega in feline retrovirosis: From theory to practice

Veterinary Immunology and Immunopathology

Volumn 143, Issue 3-4, 2011, Pages 301-306

  Doménech, Ana ^a   Miró, Guadalupe ^a   Collado, Victorio M ^a   Ballesteros, Natalia ^a   Sanjosé, Leticia ^a   Escolar, Elena ^a   Martin, Sonsoles ^a   Gomez Lucia, Esperanza ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Feline immunodeficiency virus; Feline leukemia virus; Feline retrovirus; Interferon omega; Treatment

Indexed keywords

RECOMBINANT HUMAN INTERFERON OMEGA; RECOMBINANT INTERFERON; UNCLASSIFIED DRUG; VIRBAGEN;

ARTICLE; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL TRIAL; DRUG EFFICACY; ERYTHROCYTE; FELINE RETROVIROSIS; FELINE RETROVIRUS; FEMALE; HYPERGAMMAGLOBULINEMIA; IN VIVO STUDY; INNATE IMMUNITY; MALE; NONHUMAN; RETROVIRUS; RETROVIRUS INFECTION; TREATMENT RESPONSE; VIREMIA; VIRUS DETECTION; VIRUS LOAD;

ANIMALS; ANTIVIRAL AGENTS; CATS; CD4-CD8 RATIO; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; FEMALE; HYPERGAMMAGLOBULINEMIA; IMMUNODEFICIENCY VIRUS, FELINE; INTERFERON TYPE I; LEUKEMIA VIRUS, FELINE; LEUKEMIA, FELINE; MALE; RECOMBINANT PROTEINS; VIRAL LOAD;

FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; FELINE LEUKEMIA VIRUS;

EID: 80052350887     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2011.06.008     Document Type: Article

References (43)

1. Adolf G.R. Human interferon omega - a review. Mult. Scler. 1995, 1:S44-S47.
2. Caney S. Antiviral therapy in cats: current rationale and recommendations. In Pract. 2005, 27:454-457.
3. Caney S., Helps M.A., Finerty C.R., Tasker S., Gruffydd-Jones T.J. Treatment of asymptomatic chronically FIV-infected cats with recombinant feline interferon omega. Proceedings of the annual conference of the American College of Veterinary Internal Medicine 2003.
4. Collado V.M., Doménech A., Gómez-Lucía E., Tejerizo G., Miró G. Usos del interferón en la clínica de pequeños animales. Pequeños Animales 2006, 63:68-75.
5. Collado V.M., Gómez-Lucía E., Tejerizo G., Miró G., Escolar E., Martín S., Doménech A. Effect of type I interferons on the expression of feline leukaemia virus. Vet. Microbiol. 2007, 123:180-186.
6. Collado, V.M., Domenech, A., Miró, G., Martín, S., Escolar, E., Ballesteros, N., Sanjosé, L., Gomez-Lucia, E. Epidemiological aspects and clinicopathological findings in cats naturally infected with feline leukemia virus (FeLV) and/or feline immunodeficiency virus (FIV). J. Am. Vet. Med. Assoc., submitted for publication.
7. Cummins J.M., Tompkins M.B., Olsen R.G., Tompkins W.A., Lewis M.G. Oral use of human alpha interferon in cats. J. Biol. Response Mod. 1988, 7:513-523.
8. De Mari K., Maynard L., Sanquer A., Lebreux B., Eun H.M. Therapeutic effects of recombinant feline interferon-omega on feline leukaemia virus (FeLV)-infected and FeLV/Feline immunodeficiency virus (FIV)-coinfected symptomatic cats. J. Vet. Intern. Med. 2004, 18:477-482.
9. Dunham S.P., Graham E. Retroviral infections of small animals. Vet. Clin. Small Anim. 2008, 38:879-901.
10. Gerlach N., Schimmer S., Weiss S., Kalinke U., Dittmer U. Effects of type I interferons on Friend retrovirus infections. J. Virol. 2006, 80:3438-3444.
11. Gerlach N., Gibbert K., Alter C., Nair S., Zelinskyy G., James C.M., Dittmer U. Anti-retroviral effects of type I IFN subtypes in vivo. Eur. J. Immunol. 2009, 39:136-146.
12. Gómez-Lucía E., Collado V.M., Doménech A. Effect of type-I interferon on retroviruses. Viruses 2009, 1:545-573.
13. Hartmann K. Feline leukaemia virus infection. Infectious Diseases of the Dog and the Cat 2006, 105-131. Saunders Elsevier, St. Louis. 3rd ed. C.E. Greene (Ed.).
14. Hauptmann R., Swetly P. A novel class of human type I interferons. Nucleic Acids Res. 1985, 13:4739-4749.
15. Hoover E.A., Zeidner N.S., Mullins J.I. Therapy of presymptomatic FeLV-induced immunodeficiency syndrome with AZT in combination with alpha interferon. Ann. N. Y. Acad. Sci. 1990, 616:258-269.
16. Ishida T., Shibanai A., Tanaka S., Uchida K., Mochizuki M. Use of recombinant feline interferon and glucocorticoid in the treatment of feline infectious peritonitis. J. Feline Med. Surg. 2004, 6:107-109.
17. Jameson P., Essex M. Inhibition of feline leukemia virus replication by human leukocyte interferon. Antiviral Res. 1983, 3:115-120.
18. Lehner T., Wang Y., Pido-Lopez J., Whittall T., Bergmeier L.A., Badaahmady K. The emerging role of innate immunity in protection against HIV-1 infection. Vaccine 2008, 26:2997-3001.
19. Leutenegger C.M., Klein D., Hofmann-Lehmann R., Mislin C., Hummel U., Böni J., Boretti F., Guenzburg W.H., Lutz H. Rapid feline immunodeficiency virus provirus quantitation by polymerase chain reaction using the TaqMan fluorogenic real-time detection system. J. Virol. Methods 1999, 78:105-116.
20. McCaw D.L., Boon G.D., Jergens A.E., Kern M.R., Bowles M.H., Johnson J.C. Immunomodulation therapy for feline leukemia virus infection. J. Am. Anim. Hosp. Assoc. 2001, 37:356-363.
21. Miro G., Domenech A., Escolar E., Collado V.M., Tejerizo G., De las Heras A., Gomez-Lucia E. Plasma electrophoretogram in feline immunodeficiency virus (FIV) and/or feline leukaemia virus (FeLV) infections. J. Vet. Med. A 2007, 54:203-209.
22. Mochizuki M., Nakatani H., Yoshida M. Inhibitory effects of recombinant feline interferon on the replication of feline enteropathogenic viruses in vitro. Vet. Microbiol. 1994, 69:51-53.
23. Müller D. Interferon therapy in dogs and cats. Kleintiermedizin 2002, 8:334-337.
24. Nakamura N., Sudo T., Matsuda S., Yanai A. Molecular cloning of feline interferon cDNA by direct expression. Biosci. Biotechnol. Biochem. 1992, 56:211-214.
25. Ohe K., Takahashi T., Hara D., Hara M. Sensitivity of FCV to recombinant feline interferon (rFeIFN). Vet. Res. Commun. 2008, 32:167-174.
26. Paltrinieri S., Crippa A., Comerio T., Angioletti A., Roccabianca P. Evaluation of inflammation and immunity in cats with spontaneous parvovirus infection: consequences of recombinant feline interferon-ω administration. Vet. Immunol. Immunopathol. 2007, 118:68-74.
27. Pedretti E., Paseri B., Amadori M., Isola P., Di Pede P., Telera A., Vescovini R., Quintavalla F., Pistello M. Low-dose interferon-α treatment for feline immunodeficiency virus infection. Vet. Immunol. Immunopathol. 2006, 109:245-254.
28. Pestka S., Krause C.D., Walter M.R. Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 2004, 202:8-32.
29. Pinches M.D., Helps C.R., Gruffydd-Jones T.J., Egan K., Jarrett O., Tasker S. Diagnosis of feline leukaemia virus infection by semi-quantitative real-time polymerase reaction. J. Feline Med. Surg. 2007, 9:8-13.
30. Riondato F., Gianella P., Guglielmino R., Cagnasso A., Bo S. Effects of interferon-alpha (IFN-α) therapy on peripheral blood lymphocyte subsets from FIV and FEV naturally infected cats. Vet. Res. Commun. 2003, 27:429-432.
31. Roberts R.M., Liu L., Guo Q., Leaman D., Bixby J. The evolution of the type I interferons. J. Interferon Cytokine Res. 1998, 18:805-816. (published erratum appears in J. Interferon Cytokine Res. 19 (1999) 427).
32. Rogers R., Merigan T.C., Hardy W.D., Old L.J., Kassel R. Cat interferon inhibits feline leukaemia virus infection in cell culture. Nat. New Biol. 1972, 237:270-271.
33. Sellon R.K., Hartmann K. Feline immunodeficiency virus infection. Infectious Diseases of the Dog and the Cat 2006, 131-143. Saunders Elsevier, St. Louis. 3rd ed. C.E. Greene (Ed.).
34. Sen G.C. Viruses and interferons. Annu. Rev. Microbiol. 2001, 55:255-281.
35. Steed V.P. Improved survival of four cats infected with feline leukemia virus after oral administration of interferon. Feline Pract. 1987, 17:24-30.
36. Tanabe T., Yamamoto J. Feline immunodeficiency virus lacks sensitivity to the antiviral activity of feline IFN-γ. J. Interferon Cytokine Res. 2001, 21:1039-1046.
37. Truyen U., Blewaska S., Schultheiss U. A study of the antiviral activity of interferon-omega (IFN-ω) against selected canine and feline viruses. J. Mod. Vet. Med. 2002, 10:862-864.
38. Ueda Y., Sakurai T., Yanai A. Homogeneous production of feline interferon in silkworm by replacing single amino acid code in signal peptide region in recombinant baculovirus and characterization of the product. J. Vet. Med. Sci. 1993, 55:251-258.
39. Ueda Y., Sakurai T., Kasama K., Satoh Y., Atsumi K., Hanawa S., Uchino T., Yanai A. Pharmacokinetic properties of recombinant feline interferon and its stimulatory effect on 2',5'-oligoadenylate synthetase activity in the cat. J. Vet. Med. Sci. 1993, 55:1-6.
40. Weiss R.C., Cummins J.M., Richards A.B. Low-dose orally administered alpha interferon treatment for feline leukemia virus infection. J. Am. Vet. Med. Assoc. 1991, 199:1477-1481.
41. Wonderling R., Powell T., Baldwin S., Morales T., Snyder S., Keiser K., Hunter S., Best E., McDermott M.J., Milhausen M. Cloning, expression, purification, and biological activity of five feline type I interferons. Vet. Immunol. Immunopathol. 2002, 89:13-27.
42. Yamamoto J.K., Ho E., Pedersen N.C. A feline retrovirus induced T-lymphoblastoid cell-line that produces an atypical α type of interferon. Vet. Immunol. Immunopathol. 1986, 11:1-19.
43. Zeidner N.S., Myles M.H., Mathiason-Dubard C.K., Druitt M.J., Mullins J.L., Hoover E.A. Alpha interferon (2b) in combination with zidovudine for the treatment of presymptomatic feline leukaemia virus-induced immunodeficiency syndrome. Antimicrob. Agents Chemother. 1990, 34:1749-1756.